MNK14042068: A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis

Grants and Contracts Details

StatusFinished
Effective start/end date12/4/179/30/19

Funding

  • Mallinckrodt ARD Incorporated: $25,680.00